10-Q · May 15, 2026
Merlin Labs, Inc. reported revenue of $1,002 thousand for Q1 2026, a 15.4% increase from $868 thousand in Q1 2025. Despite revenue growth, the company incurred a net loss of $90,419 thousand, significantly higher than…
Earnings analysis · 10-Q
MRLN earnings analysis
Filed August 14, 2026 · Our reading of the company's report
The latest report
Merlin’s second-quarter results showed a 29.4% year-over-year revenue decline to $2.194 million, a negative 5.4% gross margin, a negative 1,528.1% operating margin, and diluted EPS of $(1.40), materially below the…
Read full summary
Merlin’s second-quarter results showed a 29.4% year-over-year revenue decline to $2.194 million, a negative 5.4% gross margin, a negative 1,528.1% operating margin, and diluted EPS of $(1.40), materially below the $(0.25) estimate. Operating expenses continued to expand, with R&D up 139.0% to $16.387 million and G&A up 309.5% to $15.576 million, while the company used $50.896 million of operating cash in the first half. Financing raised $181.493 million and eliminated debt obligations, but persistent losses, dependence on government and aircraft-manufacturer support, and unresolved material weaknesses remain significant concerns.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $-1.4
- Gross margin
- -5.4%
- Operating margin
- -1528.1%
What stood out
-
Revenue declined on USSOCOM phase timing
Second-quarter revenue was $2.194 million, down 29.4% from $3.107 million in the prior-year quarter, primarily because one USSOCOM contract phase was completed and a new phase began.
-
Gross margin turned negative
Gross profit was a loss of $119 thousand, or a gross margin of approximately negative 5.4%, versus gross profit of $41 thousand in the prior-year quarter.
-
Engineering investment accelerated
Research and development expense increased 139.0% to $16.387 million from $6.856 million, driven by engineering hiring, outside subject-matter experts, and higher equipment and material costs.
-
Capital raises strengthened liquidity
The company reported $181.493 million of financing cash inflows for the six months ended June 30, 2026, including approximately $80.0 million of gross proceeds from the May 1 private placement.
-
Debt obligations were eliminated
The company had no debt obligations as of June 30, 2026 after repaying its PGF Loan and 2021 and 2024 LSA term loans; restricted cash was $2.570 million.
-
C-130J delivery milestone identified
Management said initial customer deliveries are currently anticipated within the next year under the C-130J program, supported by an IDIQ contract with a ceiling value of up to $105 million.
What to watch
-
Material weaknesses remain unresolved
Management concluded that disclosure controls and procedures were not effective as of June 30, 2026 because of material weaknesses involving complex transactions, segregation of duties, and IT general controls. The weaknesses could lead to material misstatements or delayed filings.
-
Aircraft data access could constrain delivery
The filing newly highlights dependence on aircraft manufacturers for proprietary technical data, interface specifications, and software. Loss or delay of access could require costly redesign and delay or terminate programs, including work associated with the $105 million IDIQ contract.
-
Large losses and cash burn require funding
The company used $50.896 million in operating cash during the first six months of 2026 while reporting a $148.846 million net loss. Management expects losses to continue for the next few years and said additional equity or debt financing may be required.
Management's outlook
No numeric revenue or EPS guidance was provided. Management stated that initial customer deliveries are currently anticipated within the next year under the C-130J IDIQ production contract, with the first Merlin Pilot deployment planned within the next three years.
Earlier filings 4
10-K · March 12, 2026
Inflection Point Acquisition Corp. IV has transitioned from a blank check company into an impending merger with Merlin Labs, confirmed by a shareholder vote on March 12, 2026. With a total trust account investment of…
10-Q · November 12, 2025
For Q3 2025, MRLN reported a net income of $83,694 driven by interest income, marking an improvement from a net loss of $47,447 in Q3 2024. The company continues to prepare for its merger with Merlin Labs, with $259.73…
10-Q · August 8, 2025
For Q2 2025, MRLN reported a net income of $2,308,843, driven primarily by interest earned on investments. The company continues to operate without generating revenue or significant operational activities, as it…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.